Advertisement

Oxygen as a Drug

  • Yoo Kuen ChanEmail author
Chapter
  • 1.3k Downloads

Abstract

Oxygen is a drug naturally available in the atmosphere. In the acutely ill patient, we administer it either from the environment at 21 % or from stored oxygen sources in higher concentrations. It is administered via nasal prongs, masks or other oxygen delivery and/or ventilator devices. Oxygen is delivered to the tissues by the cardiopulmonary system and is mainly carried by hemoglobin. Under hyperbaric conditions, more oxygen is carried in solution in the blood. Oxygen is necessary for the optimal production of ATP within the cells, which is the source of energy for all cellular function, without which cell death occurs. It is administered whenever tissue oxygen supply may be compromised, such as in low inspired oxygen conditions, poor tissue perfusion states, and inadequate or impaired hemoglobin carrying capacity. Oxygen from hyperbaric sources is used to combat air embolism and also to assist in poorly healing wounds associated with cancer therapy. Hazards of oxygen therapy include retinopathy of prematurity, lung fibrosis and seizures. Oxygen administration areas are also fire risk zones.

Keywords

Oxygen a drug ATP production Oxygen sources Oxygen therapy Hazards of oxygen 

Further Reading

  1. 1.
    Benatar SR, Hewlett AM, Nunn JF. The use of iso-shunt lines for control of oxygen therapy. Br J Anaesth. 1973;45:711–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N Engl J Med. 2011;365:1905–14.PubMedCrossRefGoogle Scholar
  3. 3.
    Costa EL, Amato MB. The new definition for acute lung injury and acute respiratory distress syndrome: is there room for improvement? Curr Opin Crit Care. 2013;19(1):16–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Davis PG, Tan A, O’Donnell CPF, Schulze A. Resuscitation of newborn infants with 100 % oxygen or air: a systematic review and meta-analysis. Lancet. 2004;364:1329–33.PubMedCrossRefGoogle Scholar
  5. 5.
    Elliot S. Erythropoiesis – stimulating agents and other methods to enhance oxygen transport. Br J Pharmacol. 2008;154:529–41.CrossRefGoogle Scholar
  6. 6.
    Leach RM, Treacher DF. The pulmonary physician in critical care. 2: oxygen delivery and oxygen consumption in the critically ill. Thorax. 2002;57:17–77.CrossRefGoogle Scholar
  7. 7.
    Martin DS, Grocott MP. Oxygen therapy in critical illness: precise control of arterial oxygenation and permissive hypoxemia. Crit Care Med. 2013;41:423–32.PubMedCrossRefGoogle Scholar
  8. 8.
    Martin DS, Grocott MP. Oxygen therapy in anaesthesia: the yin and yang of O2. Br J Anaesth. 2013;111(6):867–71.PubMedCrossRefGoogle Scholar
  9. 9.
    The BOOST II United Kingdom, Australia, and New Zealand Collaborative Groups. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368:2094–104.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.Department of Anesthesiology, Faculty of MedicineUniversity of MalayaKuala LumpurMalaysia

Personalised recommendations